Skip to content

Knowledge Hub
Careers
News & Events
Contact Us

Home
Who we are
What we do
SmartPath
Digital Walkthrough

Knowledge Hub
Careers
News & Events
Contact Us

Strategies for the modulation of phase II metabolism in a series of PKCε inhibitors

Oct 7th 2014

Back to Knowledgebase

Helpful Links

Contact Us
Careers
Safety, Health and Environment
Privacy Policy
CatSci Corporate and Social Responsibility (CSR) Policy 2024

What we do

Small Molecule Late Development
Small Molecule Early Development
Route Scouting and Selection
Analytical Science
High Potency APIs
Solid State and Preformulation
Oligonucleotides

Who we are

CatSci Ltd are an award-winning innovation partner for medicines development who are committed to creating tailored solutions from candidate selection through product launch and beyond. We break down the silos in small molecules, TACS, glues and oligonucleotides CMC development to accelerate the delivery of life-changing medicines to patients in need.

© 2024 CatSci Ltd. All rights reserved.
Registered in England & Wales.
Company No. 07466141.